In patients with heart failure, SGLT2 inhibitors after TAVI are associated with major risk reductions in a clinical trial ...
The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...
In patients with symptomatic severe aortic stenosis at intermediate or higher surgical risk, CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a lower 5-year ...
The aortic valve is a door that separates the heart from the aorta, the largest artery that carries blood to different organs of our body. As we grow older, the valve becomes dysfunctional.